CoQ10 deficiency can present in infancy as a severe encephalomyopathy or multisystemic mitochondrial disease, with features such as hypotonia, developmental delay, intractable seizures, lactic acidosis, cardiomyopathy, and failure to thrive. Reports of infantile‑onset multisystem CoQ10 deficiency describe very early presentations, sometimes in the neonatal period, with rapid neurologic deterioration and involvement of brain, heart, kidney, and liver, and many affected children die in the first months or years of life despite intensive care. The important clinical point is that, although outcomes are often poor in the most severe cases, some infants and young children show neurologic improvement or stabilization when CoQ10 deficiency is recognized early and high‑dose CoQ10 supplementation is started promptly, which is why this diagnosis is considered a treatable cause of infantile encephalomyopathy This medication is commonly used for High Cholesterol.
Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):183-8. Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur Neurol. 1997;37(4):212-8. Boitier E, Degoul F, Desguerre I, Charpentier C, François D, Ponsot G, Diry M, Rustin P, Marsac C. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci. 1998;156(1):41-6. Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E, Santorelli FM, Miranda AF, Bonilla E, Mojon DS, Barreira AA, King MP, DiMauro S. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology. 1997 May;48(5):1238-43.
Some side effects may be linked to nutrient depletion caused by this medication.
While studies demonstrate statins effectively lower LDL-C and apoB, research suggests they may also reduce CoQ10 levels. This vital antioxidant plays a crucial role in mitochondrial function, and deficiency can impact brain, muscle, kidney, and heart health. CoQ10 supplementation could be a helpful way to mitigate a potential deficiency when taking a statin therapy.
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like NAC with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.
Statin therapy can lead to side effects such as statin-associated muscle symptoms (SAMS), rhabdomyolysis myopathy, and myalgia. Research has demonstrated vitamin D is associated with deficient and insufficient status in patients taking statin drug therapy. It has also found vitamin D to be successful in preventing muscle-related side effects like SAMS. Supplementation with vitamin D should be considered to avoid a potential deficiency and to help protect against muscle related side effects.
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like alpha lipoic acid with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.
Magnesium supplements and statin medications both inhibit the HMG-CoA and have complementary effects to reducing the production of cholesterol. Magnesium has functions that are crucial to cardiovascular and general health as a catalyst to 300 healthy reactions in the body and 100 in the heart. The association between Magnesium supplementation and statins is also able to offer some protection for painful myopathy as a side effect induced by statins, which may also boost patient compliance. According to research, patients who received the statin drug atorvastatin along with a magnesium treatment had significantly increased levels of serum magnesium, HDL (the good cholesterol), as well as significantly decreased levels of total cholesterol, LDL cholesterol, and triglycerides.
Research has found vitamin E supplementation significantly increased the antioxidative capacity of LDL, which was partially abolished by statin therapy. Supplementation with vitamin E should be considered for its antioxidant and anti-inflammatory properties that may help reduce the oxidation of LDL and help protect against cardiovascular diseases.